Differential expression of VEGF isoforms and VEGF receptors in cartilaginous tumors

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 955-957

  Yukata, Kiminori ^a   Matsui, Yoshito ^a   Goto, Tomohiro ^a   Kubo, Takahiro ^a   Yasui, Natsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Alternative splicing; Angiogenesis; Cartilaginous tumors; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ARTICLE; BENIGN TUMOR; CANCER INVASION; CARTILAGE TUMOR; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOSIS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE NEOPLASMS; CHONDROBLASTOMA; CHONDROSARCOMA; CHONDROSARCOMA, MESENCHYMAL; FIBROMA; HUMANS; NEOPLASMS, CONNECTIVE TISSUE; OSTEOCHONDROMA; OSTEOSARCOMA; PROTEIN ISOFORMS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 17444417103     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Robinson CJ and Stringer SE: The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114: 853-865, 2000.
2. Enomoto H, Inoki I, Komiya K, Shiomi T, Ikeda E, Obata K, Matsumoto H, Toyama Y and Okada Y: Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 162: 171-181, 2003.
3. Handa A, Tokunaga T, Tsuchida T, Lee YH, Kijima H, Yamazaki H, Ueyama Y, Fukuda H and Nakamura M: Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int J Oncol 17: 291-295, 2000.
4. Avala G, Liu C, Nicosia R, Horowitz S and Lachman R: Microvasculature and VEGF expression in cartilaginous tumors. Hum Pathol 31: 341-346, 2000.
5. McGough RL, Aswad BI and Terek RM: Pathological neovascularization in cartilagionous tumors. Clin Orthop 397: 76-82, 2002.
6. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 1989.
7. Aigner T, Dertinger S, Vornehm SI, Dudhia J, von der Mark K and Kirchner T: Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. Am J Pathol 150: 2133-2141, 1997.
8. Matsui Y, Kimura T, Tsumaki N, Nakata K, Yasui N, Araki N, Hashimoto N, Uchida A and Ochi T: Splicing patterns of type XI collagen transcripts act as molecular markers for osteochondrogenic tumors. Cancer Lett 124: 143-148, 1998.
9. Matsui Y, Nakata K, Araki N, Ozono K, Fujita Y, Tsumaki N, Kawabata H, Yasui N, Sekiguchi K and Yoshikawa H: Alternative splicing of fibronectin transcript in osteochondrogenic tumors. Anticancer Res 21: 1103-1106, 2001.